盟科药业: management transactions · France · AMF SSE:688373 FR FR · AMF Mcap 4.0Bn€
Browse the full directors' dealings record of 盟科药业, a listed issuer based in France. Shares are listed on FR FR, under the authority of AMF. Market capitalisation: €4bn. The latest transaction was disclosed on 4 March 2026 (Purchase). Among the most active insiders: 金燕. Every trade is free.
Financial data FY ended December 2025 · cache
Income statement
Revenue 141.8 M€
Gross profit 120.2 M€ 85% margin
Net income −241.6 M€ -170.4% margin
Balance sheet & cash
Market cap 3.96 Bn€
Total debt 379.6 M€
Free Cash Flow −210.7 M€
Last declaration on 4 March 2026
Declarations 6 total
Executives ● Purchase7 SSE
1,000 shares
SSE:273000000231958180 · 4 Mar 2026
Ideal exit: 29 Nov 2026 (T+270) Executives ● Purchase7 SSE
2,000 shares
SSE:273000000231958080 · 2 Mar 2026
Ideal exit: 27 Nov 2026 (T+270) Executives ● Purchase7 SSE
300,000 shares
SSE:173000007482653980 · 11 Apr 2024
Ideal exit: 6 Jan 2025 (T+270) Executives ● Purchase11 SSE
14,000 shares
SSE:173000007471566800 · 8 Apr 2024
Ideal exit: 3 Jan 2025 (T+270) Executives ● Purchase11 SSE
70,000 shares
SSE:173000007471566820 · 8 Apr 2024
Ideal exit: 3 Jan 2025 (T+270) Executives ● Purchase11 SSE
60,000 shares
SSE:173000007445223680 · 29 Mar 2024
Ideal exit: 24 Dec 2024 (T+270)